Bacteriophages as a potential treatment for Pseudomonas aeruginosa mediated chest infections in cystic fibrosis patients
Cystic fibrosis (CF) affects between 1in 2000 and 1 in 4500 births in caucasians of European descent. It is caused by a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) resulting in abnormal membrane osmolarity. CF is a multi-organ disease, however the cause of death is most...
Main Author: | Hendon-Dunn, Charlotte |
---|---|
Published: |
University of Brighton
2011
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.543081 |
Similar Items
-
Pulmonary colonisation of patients with cystic fibrosis by Pseudomonas aeruginosa
by: Nelson, J. W.
Published: (1991) -
Environmental survival of pseudomonas aeruginosa strains in people with cystic fibrosis
by: Clifton, Dr Ian James
Published: (2009) -
The potential of bacteriophage therapy in Acinetobacter spp. infections
by: Henein, Alexandra Elisabeth
Published: (2009) -
Development of rapid tools for the early diagnosis of Pseudomonas aeruginosa pulmonary infection in patients with cystic fibrosis
by: Weisner, Abbie Michelle
Published: (2008) -
Pseudomonas, alginate biosynthesis and cystic fibrosis
by: Govan, John R. W.
Published: (1994)